Vontobel Holding
BDTX icon

Vontobel Holding’s Black Diamond Therapeutics BDTX Stock Holding History

Vontobel Holding’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.5K Buy
+10,000
New +$24.5K ﹤0.01% 1465
2024
Q4 		– Sell
-15,723
Closed -$68.4K – 1104
2024
Q3 		$68.4K Buy
+15,723
New +$85.6K ﹤0.01% 1049

Other funds holding BDTX

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Vontobel Holding's BDTX Position: Q2 2026 in Review

Vontobel Holding opened a new position in Black Diamond Therapeutics (BDTX) in Q2 2026: 10,000 shares worth $18.5K. The stake represents ﹤0.01% of the portfolio and ranks #1465 among its holdings. This is a return to the name: Vontobel Holding previously reported a position in BDTX as recently as Q3 2024.

Vontobel Holding first reported a position in BDTX in Q3 2024 and has held it in 2 quarters since. The position peaked at $68.4K in Q3 2024. 96 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • Vontobel Holding held 10,000 shares of Black Diamond Therapeutics worth $18.5K as of Q2 2026.
  • Black Diamond Therapeutics was a new Vontobel Holding position in Q2 2026.
  • Black Diamond Therapeutics made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1465 holding.
  • Vontobel Holding first reported a position in Black Diamond Therapeutics in Q3 2024 and has held it in 2 quarters since.
  • Vontobel Holding's Black Diamond Therapeutics position peaked at $68.4K in Q3 2024.
  • 96 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.